Get startedLog in
    Picture of Modus Therapeutics Holding AB logo

    MODTX — Modus Therapeutics Holding AB News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapSucker Stock
    All News

    Brief: Modus Therapeutics Submits Patent Application For Sevuparin

    Picture of Modus Therapeutics Holding AB logoModus Therapeutics Holding AB
    23/01/2023 08:33
    Jan 23 (Reuters) - Modus Therapeutics Holding AB
 MODTX.ST :
    * SUBMITS PATENT APPLICATION FOR SEVUPARIN IN KIDNEY DISEASE
    * GRANTED PATENT WOULD PROVIDE PATENT PROTECTION UNTIL AT
LEAST
2043

Source text for Eikon:  ID:nMFN7XbMw5 
Further company coverage:  MODTX.ST 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com;))

    Recent news on Modus Therapeutics Holding AB

    See all news